Peek behind the paper: mesenchymal stromal cells for the treatment of COVID-19

In this peek behind the paper, Massimiliano Gnecchi provides insights into his recent article published in Stem Cells Translational Medicine on how mesenchymal stromal cells (MSCs) are not infected with SARS-CoV-2 and could potentially be safe if used as a treatment for COVID-19.  Please can you introduce yourself and tell us more about your role?  My name is Massimiliano Gnecchi, an intensivist cardiologist with a passion for research. In fact, for many years, in addition to the care of my patients, I have been involved in basic and clinical research. I am currently Associate Professor at the University of Pavia...